Correction of Fanconi Anemia Group C Hematopoietic Stem Cells Following Intrafemoral Gene Transfer

The main cause of morbidity and mortality in Fanconi anemia patients is the development of bone marrow (BM) failure; thus correction of hematopoietic stem cells (HSCs) through gene transfer approaches would benefit FA patients. However, gene therapy trials for FA patients using ex vivo transduction...

Descripción completa

Detalles Bibliográficos
Autores principales: Habi, Ouassila, Girard, Johanne, Bourdages, Valérie, Delisle, Marie-Chantal, Carreau, Madeleine
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946959/
https://www.ncbi.nlm.nih.gov/pubmed/20885913
http://dx.doi.org/10.1155/2010/947816

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2946959/
https://www.ncbi.nlm.nih.gov/pubmed/20885913
http://dx.doi.org/10.1155/2010/947816

Ejemplares similares